Razelle Kurzrock and Shumei Kato on Immunotherapy and Hyperprogression of Disease

Leggi l'articolo originale


Drs. Kato and Kurzrock discuss the potential reasons why some cancer patients experience hyperprogression of disease while on immunotherapy treatment.

Lascia un commento